Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | XPEV | GZPZY |
|---|---|---|
| Price | $9.40 | $48.73 |
| Change today | ▲ 1.62% | ▲ 0.00% |
| Market cap | $9.02B | $9.03B |
| Return, 3 months | -28.6% | +18.9% |
| Return, year to date | -53.6% | +33.7% |
| Return, 1 year | -60.2% | +32.9% |
| P/E (TTM) | -19.4 | 17.5 |
| P/B | 2.2 | 13.1 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | 4.24% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 30 | 42 |
| 30-day volatility | 40.7% | 36.0% |
| Max drawdown, 1 year | -67.0% | -14.2% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
